enGene Holdings Inc. Common Stock – NASDAQ:ENGN
enGene Holdings Inc. Common Stock stock price today
$3.8
-2.62
-40.81%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 1 day
enGene Holdings Inc. Common Stock stock price monthly change
-29.22%
month
enGene Holdings Inc. Common Stock stock price quarterly change
-29.22%
quarter
enGene Holdings Inc. Common Stock stock price yearly change
-12.53%
year
enGene Holdings Inc. Common Stock key metrics
Market Cap | 309.93M |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | N/A |
Revenue | N/A |
EBITDA | -95.50M |
Income | -112.91M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeenGene Holdings Inc. Common Stock stock price history
enGene Holdings Inc. Common Stock stock forecast
enGene Holdings Inc. Common Stock financial statements
Average Price Target
$17.5
Potential upside: 360.52%
Analysts Price target
Financials & Ratios estimates
| Jul 2023 | 0 | -4.72M | |
|---|---|---|---|
| Oct 2023 | 0 | -82.49M | |
| Jan 2024 | 0 | -10.71M | |
| Apr 2024 | 0 | -14.98M |
| 2024-06-14 | -0.26 | -0.38 |
|---|
| Jul 2023 | 46282000 | 140.20M | 302.93% |
|---|---|---|---|
| Oct 2023 | 86959000 | 14.47M | 16.64% |
| Jan 2024 | 93421000 | 31.03M | 33.22% |
| Apr 2024 | 273528000 | 30.56M | 11.17% |
| Jul 2023 | -7.3M | -157K | 27.55M |
|---|---|---|---|
| Oct 2023 | -6.77M | -138K | 50.84M |
| Jan 2024 | -7.37M | -506K | 12M |
| Apr 2024 | -14.16M | -179K | 193.50M |
enGene Holdings Inc. Common Stock alternative data
| Dec 2023 | 33 |
|---|---|
| Jan 2024 | 33 |
| Feb 2024 | 31 |
| Mar 2024 | 31 |
| Apr 2024 | 31 |
| May 2024 | 31 |
| Jun 2024 | 31 |
| Jul 2024 | 31 |
enGene Holdings Inc. Common Stock other data
-
What's the price of enGene Holdings Inc. Common Stock stock today?
One share of enGene Holdings Inc. Common Stock stock can currently be purchased for approximately $3.8.
-
When is enGene Holdings Inc. Common Stock's next earnings date?
Unfortunately, enGene Holdings Inc. Common Stock's (ENGN) next earnings date is currently unknown.
-
Does enGene Holdings Inc. Common Stock pay dividends?
No, enGene Holdings Inc. Common Stock does not pay dividends.
-
How much money does enGene Holdings Inc. Common Stock make?
enGene Holdings Inc. Common Stock has a market capitalization of 309.93M. enGene Holdings Inc. Common Stock earned 55.14M US dollars in net income (profit) last year or -$0.38 on an earnings per share basis.
-
What is enGene Holdings Inc. Common Stock's stock symbol?
enGene Holdings Inc. Common Stock is traded on the NASDAQ under the ticker symbol "ENGN".
-
What is enGene Holdings Inc. Common Stock's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of enGene Holdings Inc. Common Stock?
Shares of enGene Holdings Inc. Common Stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does enGene Holdings Inc. Common Stock have?
As Jul 2024, enGene Holdings Inc. Common Stock employs 31 workers.
-
When enGene Holdings Inc. Common Stock went public?
enGene Holdings Inc. Common Stock is publicly traded company for more then 3 years since IPO on 1 Feb 2022.
-
What is enGene Holdings Inc. Common Stock's official website?
The official website for enGene Holdings Inc. Common Stock is engene.com.
-
How can i contact enGene Holdings Inc. Common Stock?
enGene Holdings Inc. Common Stock can be reached via phone at +51 43 324888.
-
What is enGene Holdings Inc. Common Stock stock forecast & price target?
Based on 2 Wall Street analysts` predicted price targets for enGene Holdings Inc. Common Stock in the last 12 months, the avarage price target is $17.5. The average price target represents a 360.52% change from the last price of $3.8.
enGene Holdings Inc. Common Stock company profile:
enGene Holdings Inc. Common Stock
engene.comExchange:
NASDAQ
Full time employees:
31
Industry:
Biotechnology
Sector:
Healthcare
enGene Holdings Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines through the delivery of therapeutics to mucosal tissues and other organs. Its lead product candidate is EG-70 (detalimogene voraplasmid), which is a non-viral immunotherapy to treat non-muscle invasive bladder cancer patients with carcinoma-in-situ (Cis), who are unresponsive to treatment with Bacillus Calmette-Guérin. The company was founded in 2023 and is based in Saint-Laurent, Canada.
7171 Rue Frederick Banting
Saint-Laurent, H4S 1Z9
Saint-Laurent, H4S 1Z9
CIK: 0001100663
ISIN: CA29286M1059
:
